Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Pharma — Distribution. Per the activity note to the FY2024 annual report, the company engages in wholesale trade of pharmaceutical products. Based in Tbilisi's Isani district; founded by Gogita Mebonia and Irakli Mebonia.
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Net Cash from Operating Activities | 0 | 2,909 | 2,820 | 662 | 20 | 519 | 854 | 1,016 | -16.1% |
| Net Cash used in Investing Activities | 0 | 2,278 | 2,749 | 0 | 0 | 0 | 0 | 0 | +20.7% |
| Free Cash Flow (OCF − Capex proxy) | 0 | 631 | 71 | 662 | 20 | 519 | 854 | 1,016 | +8.3% |
| Net Cash from Financing Activities | 0 | 520 | 202 | 438 | 236 | 415 | 811 | 753 | +6.4% |
| Net Change in Cash (before FX) | 0 | 111 | 131 | 224 | 216 | 104 | 43 | 263 | +15.5% |
| Effect of FX on Cash | 0 | 14 | 12 | 4 | 19 | 78 | 6 | 67 | nmf |
| Net Change in Cash (incl. FX) | 0 | 125 | 119 | 220 | 234 | 26 | 37 | 197 | +7.9% |
| Cash at Beginning of Year | 0 | 12 | 137 | 18 | 238 | 4 | 30 | 67 | +33.0% |
| Cash at End of Year | 0 | 137 | 18 | 238 | 4 | 30 | 67 | 264 | +11.6% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set.